MEdical TReatment Optimization in cardiac rehabilitation (METRO study) : a French multicenter study.

capacitéfonctionnelle cardiac rehabilitation coronary patients entraînement physique exercise training medical treatment patients coronariens physical capacity réadaptationcardiaque traitementmédical

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 24 08 2021
accepted: 28 08 2021
pubmed: 13 10 2021
medline: 15 12 2021
entrez: 12 10 2021
Statut: ppublish

Résumé

Cardiac rehabilitation (CR) is the right place to optimize the medical treatment in coronary artery disease (CAD) patients. To report the medical management in CAD patients during CR and evaluate the consequences. CAD patients who attended a CR program within less than three months of an acute coronary syndrome (ACS), a percutaneous coronary intervention (PCI), or a coronary artery bypass graft (CABG) were included in a prospective multicenter study. Medical treatments were analyzed at the beginning and at discharge of the CR stay. Results of exercise tests were compared between 4 groups. G1: unchanged medication, n=443, G2: beta-blockers or bradycardic agents adaptation n=199, G3: renin-angiotensin system (RAS) inhibitors adaptation, n=194, G4: both medications adaptation, n=164. One thousand consecutive patients were included in 23 French CR centers (85.3% males; mean age 59.9 ± 11 years). The index event was ACS (68.5%), PCI (62.6%) and CABG (36.3%). During CR, we noted an adaptation for beta-blockers in 32.1%, in other bradycardic agents (ivabradine, verapamil, diltiazem, amiodarone) in 9.5%, and in RAS inhibitors in 36.3%. Patients of group 1 had an initial resting heart rate lower than in group 2 and 4, but at the final exercise testing, the range of the decrease was more important in group 2 and 4. The combination of physical training and therapeutic modifications resulted in similar exercise capacities in the four groups, from 5.2, 5.3, 5.4 and 5.2 MET (p=0.68), to 6.3, 6.5, 6.5 and 6.1 MET (p=0.44), respectively. The METRO study showed that significant alteration in medical treatment during cardiac rehabilitation programs could take part in improving physical capacity.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac rehabilitation (CR) is the right place to optimize the medical treatment in coronary artery disease (CAD) patients.
AIMS OBJECTIVE
To report the medical management in CAD patients during CR and evaluate the consequences.
METHODS METHODS
CAD patients who attended a CR program within less than three months of an acute coronary syndrome (ACS), a percutaneous coronary intervention (PCI), or a coronary artery bypass graft (CABG) were included in a prospective multicenter study. Medical treatments were analyzed at the beginning and at discharge of the CR stay. Results of exercise tests were compared between 4 groups. G1: unchanged medication, n=443, G2: beta-blockers or bradycardic agents adaptation n=199, G3: renin-angiotensin system (RAS) inhibitors adaptation, n=194, G4: both medications adaptation, n=164.
RESULTS RESULTS
One thousand consecutive patients were included in 23 French CR centers (85.3% males; mean age 59.9 ± 11 years). The index event was ACS (68.5%), PCI (62.6%) and CABG (36.3%). During CR, we noted an adaptation for beta-blockers in 32.1%, in other bradycardic agents (ivabradine, verapamil, diltiazem, amiodarone) in 9.5%, and in RAS inhibitors in 36.3%. Patients of group 1 had an initial resting heart rate lower than in group 2 and 4, but at the final exercise testing, the range of the decrease was more important in group 2 and 4. The combination of physical training and therapeutic modifications resulted in similar exercise capacities in the four groups, from 5.2, 5.3, 5.4 and 5.2 MET (p=0.68), to 6.3, 6.5, 6.5 and 6.1 MET (p=0.44), respectively.
CONCLUSION CONCLUSIONS
The METRO study showed that significant alteration in medical treatment during cardiac rehabilitation programs could take part in improving physical capacity.

Identifiants

pubmed: 34635328
pii: S0003-3928(21)00098-6
doi: 10.1016/j.ancard.2021.08.009
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-280

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None

Auteurs

Bruno Pavy (B)

Cardiac Rehabilitation Department. Loire VendéeOcéan Hospital, 44270 Machecoul, France. Electronic address: pavy.bruno@wanadoo.fr.

Marie-Christine Iliou (MC)

Cardiac Rehabilitation Department, Corentin-Celton Hospital, 92130Issy-Les-Moulineaux, France.

Jean-Michel Guy (JM)

Cardiorespiratory Rehabilitation Center de la Loire, 42100Saint-Etienne, France.

Jean-Yves Tabet (JY)

Cardiac Rehabilitation Center les GrandsPrés, 77174 Villeneuve Saint Denis, France.

Anne Ponchon-Weess (A)

Cardiac Rehabilitation Department, Albert Schweitzer Hospital, 68003Colmar, France.

Bernard Pierre (B)

Cardiology department, CHU de la Croix Rousse, 69004Lyon, France.

Marie-Cécile Blonde (MC)

Cardiac Rehabilitation Department, Les Rosiers Clinic, 21000Dijon, France.

Franck Bire (F)

Cardiac Rehabilitation Department, Avicienne Clinic, 33500Libourne, France.

Francine Paemelaere (F)

Cardiac Rehabilitation Department, Aguiléra Clinic, 64200Biarritz, France.

Gilles Bosser (G)

paediatric and congenital cardiology department, M3C regional competences center, university hospital, 54511Vandoeuvre-les-Nancy, France.

Philippe Blanc (P)

Cardiorespiratory Rehabilitation Center, 97492Sainte Clotilde, La Réunion.

Véronique Gebuhrer (V)

Cardiac Rehabilitation Center Bayard, 69100Villeurbanne, France.

François Carré (F)

Sports Medicine Department, CHU Rennes, 35033Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH